2022 International Congress Archives - Page 95 of 153

Multimodal mechanistic disease stratification in sporadic Parkinson’s disease

T. Payne, T. Burgess, M. Sassani, S. Roscoe, S. Bradley, A. Anton, E. Reed, I. Wilkinson, H. Mortiboys, T. Jenkins, O. Bandmann (Sheffield, United Kingdom)
Multimodal MRI assessment of the substantia nigra in premotor and motor stages of parkinsonism

J. Pasquini, MJ. Firbank, L. Best, V. Foster, V. Silani, G. Petrides, DJ. Brooks, KN. Anderson, N. Pavese (Newcastle upon Tyne, United Kingdom)
Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: TALISMAN study rationale and protocol

J. Janssen Daalen, M. Meinders, B. Stunnenberg, H. Groenewoud, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)
Multiple system atrophy mimicked by mitochondrial disease.

L. Diaz-Feliz, P. Garcia-Ruiz (Madrid, Spain)
Muscarinic M2 cholinergic receptors in cervical dystonia

P. Kassavetis, M. Hosseini, K. Mente, R. Waugh, E. Shamim, W. Dieckmann, P. Herscovitch, M. Hallett, S. Horovitz (Salt Lake City, USA)
Mutant WDR45 leads to altered ferroptosis in β-propeller protein-associated neurodegeneration

S H. Diaw, C. Ganos, S. Zittel, K. Plötze-Martin, L. Kulikovskaja, A. Westenberger, M. Vos, A. Rakovic, M. Dulovic-Mahlow, K. Lohmann (Lübeck, Germany)
Mutation in TUBB4a causing from dystonia to spastic quadriparesis across one family

A. Milovanović, O. Stojiljkovic Tamaš, N. Dragašević Mišković, M. Janković, I. Novaković, M. Svetel, V. Kostić (Belgrade, Serbia)
Mutation screening and burden analysis of AOPEP in dystonia in a Chinese population

J. Lin, C. Li, H. Shang (Chengdu, China)
Mutation screening and burden analysis of MED27 in dystonia in a Chinese population

J. Lin, C. Li, H. Shang (Chengdu, China)
Mutational effects of LRRK2 I1371V in astrocytes derived from patient specific iPSCs

R. Banerjee, I. Datta, S. Jagtap, A. Raj (Bangalore, India)